2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society

Circulation. 2019 Aug 20;140(8):e333-e381. doi: 10.1161/CIR.0000000000000627. Epub 2018 Nov 6.
No abstract available

Keywords: AHA Scientific Statements; AV block; Holter monitoring; ablation; ambulatory electrocardiography; aminophylline; atrioventricular block; atropine; beta-adrenergic agonist; bradyarrhythmia; bradycardia; bundle branch block; cardiac pacing; cardiac resynchronization therapy; cardiac sinus pause; cardiac surgery; congenital heart disease; digoxin antibodies Fab fragments; electrocardiogram; glucagon; heart block; intraoperative; isoproterenol; lamin A-C; left bundle branch block; muscular dystrophies; myocardial infarction; myotonic dystrophy; pacemaker; pacing; preoperative; quality of life; right bundle branch block; sarcoidosis; shared decision-making; sick sinus syndrome; sinus arrest; sinus bradycardia syndrome; sinus node dysfunction; spinal cord injuries; syncope; theophylline; transcatheter aortic valve replacement.

Publication types

  • Practice Guideline

MeSH terms

  • Adrenergic beta-Agonists / therapeutic use
  • Algorithms
  • Bradycardia / diagnosis*
  • Bradycardia / genetics
  • Bradycardia / therapy
  • Bronchodilator Agents / therapeutic use
  • Calcium Channel Blockers / therapeutic use
  • Cardiac Conduction System Disease / diagnosis*
  • Cardiac Conduction System Disease / genetics
  • Cardiac Conduction System Disease / therapy
  • Cardiotonic Agents / therapeutic use
  • Electrocardiography / methods
  • Genetic Testing / methods
  • Humans

Substances

  • Adrenergic beta-Agonists
  • Bronchodilator Agents
  • Calcium Channel Blockers
  • Cardiotonic Agents